April 4, 2024 Comments Off on Drug Patent Expirations for the Week of March 31, 2024 Posted in: Uncategorized
EXSERVAN (riluzole) Aquestive Patent: 8,603,514 Expiration: Apr 3, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
Source
April 4, 2024 Comments Off on New patent for Rempex drug MINOCIN Posted in: Patent Added Annual Drug Patent Expirations for MINOCIN Minocin is a drug marketed by Bausch, Triax Pharms, Lederle, and Rempex and, and is included in five NDAs. It is available from two…
Source
